We have received an uptick in questions related to this substance. We felt it was best to share our policy here to bring attention to it. . OCB adheres to WADA guidelines FDA moves toward easing restrictions on certain peptides BioPharma Dive Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law BPC 157 and ipamorelin under FDA scrutiny Alex Keoskey posted on the topic LinkedIn Which non FDA (United States Food and Drug Administration) approved peptides, such as BPC 157 (Body Protection Compound 157) and TB 500 (Thymosin Beta 500), are likely legitimate for medical use under strict supervision? FDA Moves on Peptides: What Compounding Pharmacies Need to Know